Physician profile
Avery Joseph
NPI 1891351565
$3,223.84
in general payments reported to CMS, 2019-2025
13 companies · $1,111 in 2025
The $1,111 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.27 · 2023: $134 · 2024: $1,900 · 2025: $1,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,732 · Travel and Lodging: $1,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.62 |
| Travel and Lodging | $1,413.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,451.54 | 2024 | Vistaseal |
| Intuitive Surgical, INC. | $371.70 | 2025 | |
| Globus Medical, INC. | $351.60 | 2024-2025 | Corbel, Rise |
| Smith+Nephew, INC. | $166.42 | 2025 | Stravix, Collagenase Santyl, Grafix |
| Biotissue Holdings INC. | $145.34 | 2025 | |
| Cardiva Medical, INC. | $134.47 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Organogenesis INC. | $120.83 | 2025 | Puraply Wound Matrix |
| Davol INC. | $112.18 | 2025 | Phasix Mesh |
| Astrazeneca Pharmaceuticals LP | $110.50 | 2024 | Andexxa |
| Convatec INC. | $94.90 | 2024 | |
| Allergan, INC. | $78.27 | 2022 | |
| Bard Peripheral Vascular, INC. | $58.11 | 2024 | Lutonix Drug Coated Balloon |
| Integra Lifesciences Corporation | $27.98 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avery Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.